Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Wierzba
Thomas Wierzba
Henry M. Jackson Foundation for the Advancement of Military Medicine
Immunology
Medicine
Immunopathology
Antigen
cellular immunity
3
Papers
286
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients
1993
Journal of Acquired Immune Deficiency Syndromes
Deborah L. Birx
John F. Brundage
Kristin Larson
Renata J.M. Engler
Laurie J. Smith
Edward Squire
Gary B. Carpenter
Michael Sullivan
J Rhoads
Charles N. Oster
William D. James
George P. Lupton
Thomas Wierzba
Donald S. Burke
Robert R. Redfield
Show All
Source
Cite
Save
Citations (60)
A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection
1991
The New England Journal of Medicine
Robert R. Redfield
Deborah L. Birx
Nzeera Ketter
Edmund C. Tramont
Victoria R. Polonis
Charles Davis
John F. Brundage
Gale Smith
Steven Johnson
Arnold K. Fowler
Thomas Wierzba
Avigdor Shafferman
Franklin Volvovitz
Charles N. Oster
Donald S. Burke
Show All
Source
Cite
Save
Citations (225)
507 Comparison between multitest merieux inst. (MT) and intradermal delayed type hypersensitivity skin tests (ID) in HIV seropositive patients
1991
The Journal of Allergy and Clinical Immunology
W. Davis
P.M. Englar
D. Moyer
Laurie J. Smith
Thomas Wierzba
Deborah L. Birx
Show All
Source
Cite
Save
Citations (1)
1